View of Designed Tripeptides as Potent NPM1 Oligomerization Inhibitors: A Molecular Docking and Dynamics Study Toward New Anticancer Drug Candidates

Return to Article Details Designed Tripeptides as Potent NPM1 Oligomerization Inhibitors: A Molecular Docking and Dynamics Study Toward New Anticancer Drug Candidates Download Download PDF